← Back to Search

Indeterminate Pulmonary Nodules for Pulmonary Nodules

N/A
Recruiting
Led By Eric Grogan, MD
Research Sponsored by Vanderbilt-Ingram Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to approximately 2 years
Awards & highlights

Study Summary

This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.

Eligible Conditions
  • Pulmonary Nodules

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to approximately 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to approximately 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure time needed to obtain hs CYFRA 21-1 values
Measure time needed to perform radiomics
Measure time needed to provide the CBM Value to clinician
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Indeterminate Pulmonary NodulesExperimental Treatment2 Interventions
A combined biomarker model (hs-CYFRA 21-1, radiomics, Mayo) score will be obtained to estimate potential clinical utility compared to the Mayo Model.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Blood collection
2013
Completed Phase 1
~39500
Chest Computed Tomography
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Vanderbilt-Ingram Cancer CenterLead Sponsor
213 Previous Clinical Trials
60,833 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,053 Total Patients Enrolled
1 Trials studying Pulmonary Nodules
9 Patients Enrolled for Pulmonary Nodules
Eric Grogan, MDPrincipal InvestigatorVanderbilt University/Ingram Cancer Center
3 Previous Clinical Trials
4,525 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
Eric Grogan 2024. "A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06074133.
All > Nashville
~67 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top